Predictive Genetic Testing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Disease, End User, and Geography

Description

List of Tables

The predictive genetic testing market is projected to reach US$ 4.20 billion by 2031 from US$ 1.42 billion in 2024. The market is projected to register a CAGR of 17.1% from 2025 to 2031. Major factors driving market growth include the rising prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and surging preference for direct-to-consumer (DTC) genetic testing. They are propelling the acceptance of predictive genetic testing. Furthermore, increasing acceptance and funding for rare disease and carrier screening initiatives is expected to drive market growth during the forecast period. However, social and ethical implications of predictive genetic testing, high cost of genetic testing services, stringent regulatory requirements and slow product approval processes are among the market deterrents.

In the US, predictive genetic testing is deeply integrated into consumer wellness and clinical healthcare. The nation leads globally, driven by large genomics companies such as 23andMe, Myriad Genetics, and Invitae. The Genetic Information Non-discrimination Act (GINA) helps protect individuals from discrimination based on genetic risk in health insurance and employment, encouraging use of predictive testing. However, consumer genetic testing remains under scrutiny. In 2025, over two dozen states filed a lawsuit against 23andMe over its plan to sell customer genetic data amid its bankruptcy proceedings, highlighting data privacy concerns. Meanwhile, the adoption of predictive tests in clinical settings is rising, particularly for cancer risk panels and multigene tests, supported by FDA-authorized offerings and growing physician acceptance. Despite challenges around data privacy and business model sustainability, the US remains the most influential market for predictive genetic testing.

The comparative company analysis evaluates and categorizes the predictive genetic testing market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report thoroughly examines the recent significant developments and innovations by leading vendors in the global predictive genetic testing market. The key market players include Illumina, Inc, 23andMe Holding Co, F. Hoffmann-La Roche Ltd, Ambry Genetics Corp, Myriad Genetics Inc, Exact Sciences Corp, Laboratory Corp of America Holdings, Quest Diagnostics Inc, Thermo Fisher Scientific Inc., NeoGenomics Inc.

In terms of type, the predictive genetic testing market is segmented into predispositional testing and presymptomatic testing. The predispositional testing segment held a larger market share in 2024, owing to growing focus on early disease risk identification, the advances in genetic sequencing, and the rising interest in preventive healthcare give consumers the freedom to plan their lifestyle in a personalized way and to make their medical decisions proactively.

Based on disease, the predictive genetic testing market is categorized into cancer, cardiovascular diseases, metabolic diseases, and other diseases. The cancer segment accounted for the largest share of the predictive genetic testing market in 2024. Predictive genetic testing locates mutations that are passed down from the parents and increase the risk of cancer. In this way, methods for early detection, prevention, and personalized treatment become available.

Based on end-user, the predictive genetic testing market is segmented into hospital-based laboratories, diagnostic laboratories, and other end users. The hospital-based laboratories segment held a larger market share in 2024. Hospital-based laboratories are growing due to integrated genetic workflows, the expansion of precision medicine, the adoption of advanced sequencing, clinician collaboration, rising awareness, and an increasing demand for early hereditary risk detection.

Companies operating in the predictive genetic testing market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies enable market players to expand their businesses, enhance their geographic presence, and contribute to overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. The following are a few significant developments by key players in the Predictive genetic testing market.

In January 2025, 23andMe Holding Co. announced the launch of Discover23, new research offering enabling authorized collaborators to securely access the power and diversity of the 23andMe research cohort through a Trusted Research Environment (TRE) developed by Lifebit, a technology company trusted by some of the world's leading biomedical research organizations and governments.

In October 2023, 23andMe Holding Co launched Health Action Plan, a new digital tool that utilizes results from genetic reports, health history survey data, and blood and biomarker data to provide a tailored set of health recommendations to its members.

In April 2023, Ambry Genetics Corp collaborated with LifeStrands Genomics to offer clinical genetic testing services in Singapore. Both the companies will support the Clinical Implementation Pilots (CIPs) for Phase II of Singapore's National Precision Medicine (NPM) programme.

In January 2023, Ambry Genetics Corp partnered with Unilabs to enhance genetic testing services for biopharma businesses in Europe, Latin America, and the Middle East, where it does not have a physical presence. It will cater to these markets by utilising Unilabs' genomic lab services and variant interpretation skills. Ambry, on the other hand, will provide Unilabs with its variant assessment skills.

Product Code: TIPRE00041693

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Predictive Genetic Testing Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 List of Vendors in the Value Chain

5. Predictive Genetic Testing Market - Key Market Dynamics

5.1 Predictive Genetic Testing Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Genetic Diseases
- 5.2.2 Increasing Awareness and Acceptance of Personalized Medicines
- 5.2.3 Surging Preference for Direct-To-Consumer (DTC) Genetic Testing
5.3 Market Restraints
- 5.3.1 Social and Ethical Implications of Predictive Genetic Testing
- 5.3.2 High Cost of Genetic Testing Services
- 5.3.3 Stringent Regulatory Requirements and Slow Product Approval Processes
5.4 Market Opportunities
- 5.4.1 Untapped Emerging Markets in Developing Countries
- 5.4.2 Increasing Acceptance and Funding for Rare Disease and Carrier Screening Initiatives
- 5.4.3 Expansion of At-Home Testing Kits
5.5 Future Trends
- 5.5.1 Artificial Intelligence-Powered Genetic Testing
- 5.5.2 Widespread Adoption of NGS and PCR Technologies in Genetic Testing
- 5.5.3 Rising Demand for Early Disease Detection
5.6 Impact of Drivers and Restraints:

6. Predictive Genetic Testing Market - Global Market Analysis

6.1 Predictive Genetic Testing Market Revenue (US$ Million), 2021-2031
6.2 Predictive Genetic Testing Market Forecast Analysis

7. Predictive Genetic Testing Market Analysis - by Type

7.1 Predispositional Testing
- 7.1.1 Overview
- 7.1.2 Predispositional Testing: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Presymptomatic Testing
- 7.2.1 Overview
- 7.2.2 Presymptomatic Testing: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)

8. Predictive Genetic Testing Market Analysis - by Disease

8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Cardiovascular Diseases
- 8.2.1 Overview
- 8.2.2 Cardiovascular Diseases: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Metabolic Diseases
- 8.3.1 Overview
- 8.3.2 Metabolic Diseases: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Other Diseases
- 8.4.1 Overview
- 8.4.2 Other Diseases: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)

9. Predictive Genetic Testing Market Analysis - by End User

9.1 Hospital-Based Laboratories
- 9.1.1 Overview
- 9.1.2 Hospital-Based Laboratories: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Other End Users
- 9.3.1 Overview
- 9.3.2 Other End Users: Predictive Genetic Testing Market - Revenue and Forecast to 2031 (US$ Million)

10. Predictive Genetic Testing Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Predictive Genetic Testing Market Overview
- 10.1.2 North America: Predictive Genetic Testing Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Type
  - 10.1.2.2 North America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Disease
  - 10.1.2.3 North America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Predictive Genetic Testing Market Breakdown, by Type
    - 10.1.3.1.2 United States: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.1.3.1.3 United States: Predictive Genetic Testing Market Breakdown, by End User
  - 10.1.3.2 Canada: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Predictive Genetic Testing Market Breakdown, by Type
    - 10.1.3.2.2 Canada: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.1.3.2.3 Canada: Predictive Genetic Testing Market Breakdown, by End User
  - 10.1.3.3 Mexico: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Predictive Genetic Testing Market Breakdown, by Type
    - 10.1.3.3.2 Mexico: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.1.3.3.3 Mexico: Predictive Genetic Testing Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Predictive Genetic Testing Market Overview
- 10.2.2 Europe: Predictive Genetic Testing Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Type
  - 10.2.2.2 Europe: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Disease
  - 10.2.2.3 Europe: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 Germany: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 Germany: Predictive Genetic Testing Market Breakdown, by Type
    - 10.2.3.1.2 Germany: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.2.3.1.3 Germany: Predictive Genetic Testing Market Breakdown, by End User
  - 10.2.3.2 United Kingdom: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 United Kingdom: Predictive Genetic Testing Market Breakdown, by Type
    - 10.2.3.2.2 United Kingdom: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.2.3.2.3 United Kingdom: Predictive Genetic Testing Market Breakdown, by End User
  - 10.2.3.3 France: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Predictive Genetic Testing Market Breakdown, by Type
    - 10.2.3.3.2 France: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.2.3.3.3 France: Predictive Genetic Testing Market Breakdown, by End User
  - 10.2.3.4 Italy: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Italy: Predictive Genetic Testing Market Breakdown, by Type
    - 10.2.3.4.2 Italy: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.2.3.4.3 Italy: Predictive Genetic Testing Market Breakdown, by End User
  - 10.2.3.5 Spain: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Spain: Predictive Genetic Testing Market Breakdown, by Type
    - 10.2.3.5.2 Spain: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.2.3.5.3 Spain: Predictive Genetic Testing Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Predictive Genetic Testing Market Breakdown, by Type
    - 10.2.3.6.2 Rest of Europe: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.2.3.6.3 Rest of Europe: Predictive Genetic Testing Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Predictive Genetic Testing Market Overview
- 10.3.2 Asia Pacific: Predictive Genetic Testing Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Type
  - 10.3.2.2 Asia Pacific: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Disease
  - 10.3.2.3 Asia Pacific: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Predictive Genetic Testing Market Breakdown, by Type
    - 10.3.3.1.2 China: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.3.3.1.3 China: Predictive Genetic Testing Market Breakdown, by End User
  - 10.3.3.2 Japan: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Predictive Genetic Testing Market Breakdown, by Type
    - 10.3.3.2.2 Japan: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.3.3.2.3 Japan: Predictive Genetic Testing Market Breakdown, by End User
  - 10.3.3.3 India: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Predictive Genetic Testing Market Breakdown, by Type
    - 10.3.3.3.2 India: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.3.3.3.3 India: Predictive Genetic Testing Market Breakdown, by End User
  - 10.3.3.4 Australia: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Predictive Genetic Testing Market Breakdown, by Type
    - 10.3.3.4.2 Australia: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.3.3.4.3 Australia: Predictive Genetic Testing Market Breakdown, by End User
  - 10.3.3.5 South Korea: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Predictive Genetic Testing Market Breakdown, by Type
    - 10.3.3.5.2 South Korea: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.3.3.5.3 South Korea: Predictive Genetic Testing Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Predictive Genetic Testing Market Breakdown, by Type
    - 10.3.3.6.2 Rest of APAC: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.3.3.6.3 Rest of APAC: Predictive Genetic Testing Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Predictive Genetic Testing Market Overview
- 10.4.2 Middle East and Africa: Predictive Genetic Testing Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Type
  - 10.4.2.2 Middle East and Africa: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Disease
  - 10.4.2.3 Middle East and Africa: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Predictive Genetic Testing Market Breakdown, by Type
    - 10.4.3.1.2 Saudi Arabia: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.4.3.1.3 Saudi Arabia: Predictive Genetic Testing Market Breakdown, by End User
  - 10.4.3.2 South Africa: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Predictive Genetic Testing Market Breakdown, by Type
    - 10.4.3.2.2 South Africa: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.4.3.2.3 South Africa: Predictive Genetic Testing Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Predictive Genetic Testing Market Breakdown, by Type
    - 10.4.3.3.2 United Arab Emirates: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.4.3.3.3 United Arab Emirates: Predictive Genetic Testing Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Predictive Genetic Testing Market Breakdown, by Type
    - 10.4.3.4.2 Rest of Middle East and Africa: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.4.3.4.3 Rest of Middle East and Africa: Predictive Genetic Testing Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Predictive Genetic Testing Market Overview
- 10.5.2 South and Central America: Predictive Genetic Testing Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Type
  - 10.5.2.2 South and Central America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Disease
  - 10.5.2.3 South and Central America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Predictive Genetic Testing Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Predictive Genetic Testing Market Breakdown, by Type
    - 10.5.3.1.2 Brazil: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.5.3.1.3 Brazil: Predictive Genetic Testing Market Breakdown, by End User
  - 10.5.3.2 Argentina: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Predictive Genetic Testing Market Breakdown, by Type
    - 10.5.3.2.2 Argentina: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.5.3.2.3 Argentina: Predictive Genetic Testing Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Predictive Genetic Testing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Predictive Genetic Testing Market Breakdown, by Type
    - 10.5.3.3.2 Rest of South and Central America: Predictive Genetic Testing Market Breakdown, by Disease
    - 10.5.3.3.3 Rest of South and Central America: Predictive Genetic Testing Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Merger and Acquisition
12.4 Other Developments

13. Company Profiles

13.1andMe Holding Co
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Illumina, Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Ambry Genetics Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Myriad Genetics Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Exact Sciences Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Laboratory Corp of America Holdings
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Quest Diagnostics Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Thermo Fisher Scientific Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 NeoGenomics Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 List of Abbreviations